Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical significance of miR-218-5p and its potential mechanism in acute pulmonary embolism.

Created on 28 Sep 2026

Authors

Rui Jin, Jinping Tong, Aiwen Zhang, Fang Liu

Published in

Annals of agricultural and environmental medicine : AAEM. Volume 33. Issue 3. Pages 293-299. Sep 21, 2026. Epub May 07, 2026.

Abstract

Acute pulmonary embolism (APE), a life-endangering cardiovascular acute disorder, brings about difficulties in early diagnosis. The aim of the study is to investigate the expression of miR-218-5p, its clinical significance, and mechanism in APE.
A total of 102 APE patients and 98 healthy controls were recruited, with miR-218-5p levels assayed by qRT-PCR; its diagnostic value was assessed by ROC curves. Pearson correlation and multivariate logistic regression analyzed associations with clinical indicators and independent predictive value. Oxygen-glucose deprivation/reoxygenation (OGD/R)-induced human pulmonary artery endothelial cells (HPAECs) were transfected with miR-218-5p mimic to observe the effects on apoptosis, proliferation, inflammation, and oxidative stress. Bioinformatics and dual-luciferase assays validated miR-218-5p targeting CREB1.
Serum miR-218-5p was significantly downregulated in APE (P<0.0001) with high diagnostic efficacy (AUC=0.893). It positively correlated with D-dimer (r=0.759) and Wells scores (r=0.703; P<0.0001) and was an independent APE risk factor (OR=0.053; P<0.0001). In vitro, miR-218-5p overexpression reduced OGD/R-induced HPAEC apoptosis, promoted proliferation, inhibited inflammation (IL-6, IL-1β, TNF-α) and oxidative stress (MDA, ROS), and restored SOD activity (P<0.01). Mechanistically, miR-218-5p directly targeted CREB1 to suppress its expression.
miR-218-5p is downregulated in APE, as a potential diagnostic biomarker. It targets CREB1 to modulate apoptosis, inflammation, and oxidative stress, thereby contributing to APE pathogenesis.

PMID:
42802946
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement